BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 6, 2008
View Archived Issues
Addition of saxagliptin to a sulfonylurea or thiazolidinedione improves glucose control
Read More
Sucrose octasulphate demonstrates oral antirheumatic activity
Read More
Galectin-3 as potential therapeutic target in post-ischemic functional recovery
Read More
New treatment option for Wilson's disease disclosed in recent SSV patent
Read More
Novel treatments for endocrine-associated disorders imparted in recent patents
Read More
Recent GSK patent describes new analgesic agents
Read More
MediGene spins out mTCR technology platform to newly founded Immunocore
Read More
PharmAthene enters into strategic alliance with Panacea Biotec
Read More
OrthoLogic changes trade name to Capstone Therapeutics
Read More
Kringle files IND with FDA for phase I clinical trial of recombinant human HGF in renal disease
Read More
Affymetrix and MPI sign agreement for Affymetrix microarray technology in cancer
Read More
pSivida reports 6-month interim readout of the human PK Iluvien study
Read More
TorreyPines reports successful end-of-phase II meeting with FDA for tezampanel
Read More
Exelixis files IND with the FDA for XL-888
Read More
Ironwood raises USD 50 million for linaclotide phase III development program
Read More
Aeolus receives milestone payment from ARCA following acceptance of bucindolol NDA
Read More
PPD acquires InnoPharm
Read More
RegeneRx seeks strategic partner to develop RGN-457 for cystic fibrosis
Read More
Meda and Recordati sign long-term agreement for Lercadip in Spain
Read More
Mentor reports positive results from phase III clinical trial of PurTox in glabellar rhytides
Read More
Emergent signs new contract with HHS to supply anthrax vaccine BioThrax for SNS
Read More
Dara completes toxicology studies neeeded for phase I trials of DB-959, gives pipeline update
Read More
Daiichi Sankyo and Kuhnil initiate enrollment in phase II trial of nimotuzumab in gastric cancer
Read More
Kyowa Hakko Kogyo and Kirin Pharma complete business merger
Read More
Toctino receives marketing authorization in Germany
Read More
R&D highlights from the UBS Global Life Sciences Conference in New York: Enobia Pharma
Read More
Interim analysis of phase II sorafenib study shows safety and activity against thyroid cancer
Read More
